Morgan Stanley Maintains Equal-Weight on Exelon, Lowers Price Target to $50
Morgan Stanley analyst David Arcaro maintains Exelon (NASDAQ:EXC) with a Equal-Weight and lowers the price target from $53 to $50.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga